Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)

CUSIP: 81728J109

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-136,191
Put/Call ratio
136%
SEC-reported price per share
$3.80
Indexed holders
45
Value change
-$140,014
Number of buys
16
Open additional details 1 more signal available
Number of sells
22
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,385,263

Security key

81728J109

Report period

Q1 2024

Indexed institutions

45

Top holders

10

Ownership snapshot

Top reported holders of SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Joseph C. Sardano
Disclosed value leader
Stephen Brad Cohen
Comparable rows
1/15
Latest evidence
31 Dec 2023
13D/G 3/4/5 13F Lead comparable stake: 7.1% 14 rows are not safely comparable across share classes. 13D/G row: Joseph C. Sardano Showing 1-6 of 15 holder rows.

Quick read

Joseph C. Sardano leads the comparable SEC ownership view at 7.1%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Joseph C. Sardano's linked filing trail.
Comparable ownership Top 1
Joseph C. Sardano 7.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Joseph C. Sardano
13D/G
7.1%
Reported 13D/G · 14 Sep 2023
—
1,175,293 shares
$0 14 Sep 2023
Stephen Brad Cohen
3/4/5
EXECUTIVE VICE PRESIDENT
—
denominator unverified
$2,209,356
830,585 shares
— 15 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,838,563
779,052 shares
— 31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$686,000
290,748 shares
— 31 Dec 2023
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$417,130
176,750 shares
— 31 Dec 2023
Samuel O'Rear
3/4/5
Director
—
denominator unverified
$381,896
143,570 shares
— 08 May 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
45
Shares
2,481,212
Indexed holders
45
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 indexed holders
40
Q1 2024 indexed holders
45
Indexed holder difference
5
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .